TLR9 and type 1 diabetes mellitus: In addition, TLR9 activation and the release of interferon-beta (IFN-β) promote the expansion of diabetogenic CD8+ T cells in the pancreatic lymph nodes (PLNs) of NOD mice, thus increasing T1D severity [20].